Cara Therapeutics Study Site

San Antonio, Texas 78251

0 studies enrolling now · 12 studies all time

What they study most

Arthritis, Atopic Dermatitis, Chronic Kidney Diseases, Healthy, Hemodialysis, Joint Diseases, Musculoskeletal Diseases, Notalgia Paresthetica, Osteoarthritis, Hip, Osteoarthritis, Knee, Post Abdominal Surgery Pain, Pruritus

Studies at this site

• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica — Stopped early
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis — Stopped early
• A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus — Completed
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT) — Completed
• CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus — Completed
• A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1) — Completed
• CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus — Completed
• Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus — Completed
• A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee — Completed
• Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus — Completed
• Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects — Completed
• A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery — Completed